Adaptive Biotechnologies to Present at the Morgan Stanley 2020 Healthcare Conference
September 01 2020 - 4:03PM
Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a
commercial stage biotechnology company that aims to translate the
genetics of the adaptive immune system into clinical products to
diagnose and treat disease, today announced it will be
participating in the upcoming Morgan Stanley Virtual Healthcare
Conference.
Adaptive Biotechnologies’ management is
scheduled to participate in a fireside chat on Tuesday, September
15th at 10:15 a.m. Pacific Time / 1:15 p.m. Eastern Time.
Interested parties may access a live and archived webcast of the
presentation on the “Investors” section of the company website at:
www.adaptivebiotech.com.
About Adaptive
BiotechnologiesAdaptive Biotechnologies is a
commercial-stage biotechnology company focused on harnessing the
inherent biology of the adaptive immune system to transform the
diagnosis and treatment of disease. We believe the adaptive immune
system is nature’s most finely tuned diagnostic and therapeutic for
most diseases, but the inability to decode it has prevented the
medical community from fully leveraging its capabilities. Our
proprietary immune medicine platform reveals and translates the
massive genetics of the adaptive immune system with scale,
precision and speed to develop products in life sciences research,
clinical diagnostics and drug discovery. We have two commercial
products and a robust clinical pipeline to diagnose, monitor and
enable the treatment of diseases such as cancer, autoimmune
conditions and infectious diseases. Our goal is to develop and
commercialize immune-driven clinical products tailored to each
individual patient.
ADAPTIVE MEDIA Beth Keshishian
917-912-7195 media@adaptivebiotech.com
ADAPTIVE INVESTORS Karina Calzadilla, Vice
President, Investor Relations 201-396-1687 Carrie
Mendivil, Gilmartin Group investors@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Apr 2023 to Apr 2024